drugset / Trial / NCT02909569

Relieving Chronic Itch: Oral Medication

NCT02909569

NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the effect of twice daily dose of INCB39110 in the treatment of itch in adults.

Timeline

Start
2018-08
Primary completion
2018-10-09
Completion
2018-10-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Itacitinib Small molecule 400 mg Oral

Indications

No indication recorded.